| Patent Number |
Title Of Patent |
Date Issued |
| 6232441 |
PIGR-1, a member of immunoglobulin gene superfamily |
May 15, 2001 |
| PIGR-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PIGR-1 polypeptides and polynucleotides in the design of protocols for the treatment of rheumatoid arthritis (RA), mul |
| 6114515 |
PIGRL-1, a member of immunoglobulin gene superfamily |
September 5, 2000 |
| PIGRL-1 polypeptide and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PIGRL-1 polypeptide and polynucleotides in the design of protocols for the treatment of Hyper-IgM Immunodeficiency (HIM), |
| 6046030 |
Human LIG-1 homolog (HLIG-1) |
April 4, 2000 |
| HLIG-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HLIG-1 polypeptides and polynucleotides in the design of protocols for the treatment of neurological disorders such as |
| 6020161 |
PIGR-1, a member of immunoglobulin gene superfamily |
February 1, 2000 |
| PIGR-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PIGR-1 polypeptides and polynucleotides in the design of protocols for the treatment of rheumatoid arthritis (RA), mul |
| 5422274 |
Internal deletion mutants of soluble T4(CD4) |
June 6, 1995 |
| This invention provides a therapeutic agent capable of specifically forming a complex with human immunodeficiency virus envelope glycoprotein which comprises a polypeptide. In one embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in |
| 5110906 |
Derivatives of soluble T-4 |
May 5, 1992 |
| This invention provides a therapeutic agent capable of specifically forming a complex with human immunodeficiency virus envelope glycoprotein which comprises a polypeptide. In one embodiment of the invention, the amino acid sequence of the polypeptide comprises the amino acid sequence sh |
